NEK2 induces osteoclast differentiation and bone destruction via heparanase in multiple myeloma

dc.contributor.authorHao, M.
dc.contributor.authorFranqui-Machin, R.
dc.contributor.authorXu, H.
dc.contributor.authorShaughnessy, J., Jr.
dc.contributor.authorBarlogie, B.
dc.contributor.authorRoodman, D.
dc.contributor.authorQuelle, D. E.
dc.contributor.authorJanz, S.
dc.contributor.authorTomasson, M. H.
dc.contributor.authorSanderson, R. D.
dc.contributor.authorQiu, L.
dc.contributor.authorFrech, I.
dc.contributor.authorTricot, G.
dc.contributor.authorZhan, F.
dc.contributor.departmentMedicine, School of Medicineen_US
dc.date.accessioned2018-04-23T19:32:50Z
dc.date.available2018-04-23T19:32:50Z
dc.date.issued2017-07
dc.eprint.versionFinal published versionen_US
dc.identifier.citationHao, M., Franqui-Machin, R., Xu, H., Shaughnessy, J., Barlogie, B., Roodman, D., … Zhan, F. (2017). NEK2 induces osteoclast differentiation and bone destruction via heparanase in multiple myeloma. Leukemia, 31(7), 1648–1650. http://doi.org/10.1038/leu.2017.115en_US
dc.identifier.urihttps://hdl.handle.net/1805/15895
dc.language.isoen_USen_US
dc.publisherNature Publishing Groupen_US
dc.relation.isversionof10.1038/leu.2017.115en_US
dc.relation.journalLeukemiaen_US
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 United States
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/3.0/us
dc.sourcePMCen_US
dc.subjectOsteoclastsen_US
dc.subjectMultiple myelomaen_US
dc.subjectBone marrow -- Diseasesen_US
dc.titleNEK2 induces osteoclast differentiation and bone destruction via heparanase in multiple myelomaen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
leu2017115a.pdf
Size:
359.45 KB
Format:
Adobe Portable Document Format
Description:
Main article
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: